ClinicalTrials.gov
ClinicalTrials.gov Menu

Patients With Hemorrhoids Referred to a Surgical Specialist Department

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01706601
Recruitment Status : Unknown
Verified March 2015 by Solveig Elmér, Karolinska Institutet.
Recruitment status was:  Active, not recruiting
First Posted : October 15, 2012
Last Update Posted : March 10, 2015
Sponsor:
Collaborator:
Ersta Hospital, Sweden
Information provided by (Responsible Party):
Solveig Elmér, Karolinska Institutet

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Hemorrhoids is the most common disease in rectum with a prevalence of 30 % of population. This means that many patients are referred to surgical specialist reception with diagnosis hemorrhoidal disease. The aim of this study is to describe population of patients with hemorrhoidal disease that are referred to a specialised colorectal unit and to determine what treatment they are given at a general practitioner as well as in colorectal unit.

Condition or disease
Hemorrhoids

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Estimated Enrollment : 800 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Patients With Hemorrhoids Referred to a Surgical Specialist Department
Study Start Date : February 2011
Estimated Primary Completion Date : December 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hemorrhoids
U.S. FDA Resources

Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Hemorrhoids
Patient with hemorrhoids


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Correct diagnosis? [ Time Frame: patients visiting Ersta Hospital between 2007-2009 ]

Secondary Outcome Measures :
  1. treatment of hemorrhoids [ Time Frame: patients visiting Ersta Hospital between 2007-2009 ]
    Surgical or conservative treatment, results and number of patients in the groups


Other Outcome Measures:
  1. Examination/treatment [ Time Frame: Before visiting Ersta hospital ]
    Examination and treatment given by general practitioner

  2. Operation/complication [ Time Frame: postoperatively ]
    Which operations were performed, complications?, reinterventions?

  3. genus [ Time Frame: between 2007-2009 ]
    Did men and women got the same treatment

  4. Treated elsewhere [ Time Frame: after compleated treatment at Ersta hospital ]

Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients whith hemorrhoids
Criteria

Inclusion Criteria:

  • all patients with diagnosis hemorrhoidal disease that are referred to a surgical specialist department

Exclusion Criteria:

Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01706601


Locations
Sweden
Ersta hospital
Stockholm, Sweden, 116 91
Sponsors and Collaborators
Karolinska Institutet
Ersta Hospital, Sweden
Investigators
Principal Investigator: Solveig Elmér, MD Karolinska Institutet
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Solveig Elmér, MD, Karolinska Institutet
ClinicalTrials.gov Identifier: NCT01706601     History of Changes
Other Study ID Numbers: 2010/1108-31/1
First Posted: October 15, 2012    Key Record Dates
Last Update Posted: March 10, 2015
Last Verified: March 2015

Additional relevant MeSH terms:
Hemorrhoids
Rectal Diseases
Intestinal Diseases
Gastrointestinal Diseases
 Digestive System Diseases
Vascular Diseases
Cardiovascular Diseases